Galera Therapeutics, Inc. (GRTX): SCHEDULE 13D filed Apr 10, 2026

Form type

SCHEDULE 13D

Filing date

Apr 10, 2026

Accession number

0000905148-26-001633

Filer

Galera Therapeutics, Inc. (CIK 1563577)